Did you know there’s even more we can do to promote your episode? Find out more…
Matthew Stober, CEO at Abzena discusses the need for global harmonization with regulatory agencies within the biopharma sector…
J.D Mowrey, CEO at KBI Biopharma shares valuable insights on the new absorption business model in the biopharma outsourcing space..
CEO at Microsize joins the podcast to discuss the importance of banding together in the outsourcing space as you can’t do it all yourself…
Howard Berman Founder & CEO at Coya Therapeutics tells the story of how a neurology appointment inspired him to start his own biotech.
Pamela Bush from Predictive Oncology shares how active machine learning is speeding up clinical trials for better outcomes for patients…
Tushar Misra from Mersana Therapeutics joins the podcast to discuss how his CDMO is leading the way with ADCs for harsh cancers.
Mike Martin from CAI tells all on his inspiring story from a rural farm boy, to one of the world’s global Pharma leaders.
Kathy Fernando, Pfizer Ignite & Pfizer CentreOne, brings insight into the often-forgotten mRNA that rose to top priority on the vaccine tree.
Tim Scott from AustinPX joins the podcast to discuss the founding story of Pharamatek, disruptive CDMO technology and more.
Molecule to Market is joined by Dr. Graham Wylie who discusses how he came to work with his close family at Medical Research Network.
